1 Lecturer of Pediatrics, Pediatric Department, Faculty of Medicine, Minia University, Egypt. Address: Mina University, Faculty of Medicine, Minia, Egypt.

2 Lecturer of Clinical Pathology, Department of Clinical Pathology, Faculty of Medicine, Minia University, Egypt.


Seizures may occur in as many as 1% of children. The most urgent type of seizures is generalized tonic-clonic seizures (GTCS). N-terminal prohormone of brain natriuretic peptide (NT‐proBNP) has been considered as a promising biomarker in numerous acute illnesses. We aimed to evaluate usefulness of NT‐proBNP for diagnosis of generalized seizures in children.
Materials and Methods
This prospective case control study was conducted upon 80 children who were classified into four groups; Group I: included 20 patients with idiopathic generalized epileptic seizures. Group II: included 20 patients with focal epileptic seizures. Group III: included 20 patients with febrile seizures. Group IV: included 20 apparently healthy, age and sex matched children as a normal control. Complete blood count (CBC), blood chemistries, including random blood glucose, calcium, sodium, C-reactive protein (CRP) level, serum prolactin and NT‐proBNP were performed for all children.
Our results revealed significant increase of both prolactin and NT‐proBNP in generalized epileptic and febrile seizure groups than in focal epileptic and control groups (p< 001). The ROC curve analysis showed NT‐proBNP, at a cut-off value of > 384 pg/ml, sensitivity (90 %), and specificity (70.2%) which was near the results of prolactin at a cut-off value> 25.9 ng/ml, and showed sensitivity (95.1%), and specificity (71.3%).
Based on the results, NT‐proBNP increase in generalized seizures either epileptic or febrile; and may be a promising marker to adjust the diagnosis of it at the emergency setting, when history and clinical presentation are equivocal.


[1] Martindale JL, Goldstein JN, Pallin DJ. Emergency department seizure epidemiology. Emerg Med Clin North Am. 2011;29(1):15-27. doi: 10.1016/j.emc.2010.08.002. Review. PubMed PMID: 21109099.
[2] Hamiwka LD, Singh N, Niosi J, & Wirrell EC.  Diagnostic inaccuracy in children referred with "first seizure": role for a first seizure clinic. Epilepsia.2007;48(6):10626. doi:10.1111/j.15281167.2007.01018.x. PubMed PMID: 17553117.
[3] Nass RD,  Meiling S, Andrié RP, Elger CE, Surges R. Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures. BMC Neurology.2017; 17:187. DOI 10.1186/s12883-017-0965-4
[4] Wahab A. Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development. Pharmaceuticals (Basel).2010;3(7):2090–2110. doi:10.3390/ph3072090
[5] Chaurasiya OS, Gupta P, Kaushik A, Yadav R. Usefulness of Serum Prolactin in Differentiating Epileptic and Pseudoseizures in Children. People’s Journal of Scientific Research.2013;6(1):29–32.
[6]  Tatlı B,  Güler S. Non epileptic paroxysmal events in childhood. Turk Pediatri Ars.2010;52(2):59–65.
[7] Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in
porcine brain. Nature. 1998;332:78–81. doi: 10.1038/332078a0
[8] Davidson NC, Struthers AD.  Brain natriuretic peptide. J Hypertens. 1994;12:329–36. doi:
[9] Jan SL, Lin SJ, Fu YC, Lin MC, Chan SC, Hwang B. Plasma B-type natriuretic
peptide study in children with severe enterovirus 71 infection: a pilot study.
Int J Infect Dis. 2013;17:e1166–71. doi:10.1016/j.ijid.2013.06.012.
[10] McLean AS, Huang SJ. Brain not processing: is finding a role for BNP in sepsis like fitting a square peg into a round hole? Crit Care. 2014;18:161. doi:10.1186/cc13960
[11] Jan SL, Fu YC, Hwang B, Lin SJ. B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study. Biomarkers.
2012;17:166–71. doi:10.3109/1354750X.2011.649494
[12] Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–7. doi:10.1056/NEJMoa020233
[13] Olalla J, Crespo E, De la Torre J, Sempere M, Del Arco A, Prada JL, et al.
Factors related to NT-proBNP levels in HIV patients aged over 40 years. AIDS Res Ther. 2015;12:17. doi:10.1186/s12981-015-0058-7.
[14] Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open. 2015;5:e006703. doi:10.1136/bmjopen-2014-006703.
[15] Rajaniemi SM, Hautala N, Sironen T, Vainio O, Vapalahti O, Vaheri A, et al. Plasma B-type natriuretic peptide (BNP) in acute Puumala hantavirus infection. Ann Med. 2014;46:38–43. doi:10.3109/07853890.2013.862960.
[16] Deng, H., Zhang, Y., Li Y, Zhang Y,  Xie Y, Wang j, et al. N-terminal pro-brain natriuretic peptide levels associated with severe hand, foot and mouth disease. BMC Infect Dis 16, 585 (2016).
[17] Fisher RSCross JHFrench JAHigurashi NHirsch EJansen FE, et al. Operational classification of seizure types by the international league against epilepsy. Position paper of the ILAE commission for classification and terminology. Epilepsia.2017; 58(4):531–42. doi: 10.1111/epi.13670
[18] Leung AK, Hon KL, Leung TN. Febrile seizures: an overview. Drugs Context. 2018 Jul 16;7:212536. doi: 10.7573/dic.212536.
[19] Biyani G, Kumar S, Chatterjee K, Sen S, Mandal PK , Mukherjee M.  Leukocyte count and C reactive protein as diagnostic factors in febrile convulsion. Asian Journal of Medical Sciences.2017; 8:56-8. doi: 10.3126/ajms.v8i2.16331.
[20] Abdel Salam O, El Sadek S, Abdel-Moneim M and Ahmed ZM. Can Serum Levels of C-Reactive Protein (CRP), Interleukin-6 and Copeptin Discriminate between Simple and Complex Febrile Seizures?. INDJ. 2016; 8(2):1-11.
 [21] Rauchenzauner M, Haberlandt E, Foerster S, Ulmer H, Laimer M, Ebenbichler CF, et al. Brain-type natriuretic peptide secretion following febrile and afebrile seizures - a new marker in childhood epilepsy?. Epilepsia. 2007 Jan;48(1):101-6. doi: 10.1111/j.1528-1167.2006.00837.x. 
 [22] Zijlmans M, Flanagan D, Gotman J. Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia 2002; 43:847–854. Doi: 10.1046/j.1528-1157.2002.37801.x
[23] Levin ER, Gardner DG, Samson WK. Natriuretic peptides. The New England Journal of Medicine 1998; 339:321–328. DOI:10.1056/NEJM199807303390507
[24] Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke
J et al.  Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997; 349:245–249. DOI:10.1016/s0140-6736(96)08093-2
 [25] Sviri GE, Shik V, Raz B, Soustiel JF. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochirurgica (Wien) 2003;145:851– 860 DOI:10.1007/s00701-003-0101-7
[26] Franzoni MF, Canonaco M, Frova A,Tavolaro R. Brain natriuretic peptide (BNP)-like immunoreactivity in the central nervous system of the crested newt. European Journal of Histochemistry 1992; 36:455–466.
[27] Perrone BL,Vari RC, Kreisman NR. Recurrent seizures alter renal function and plasma atrial natriuretic peptide levels in rats. Epilepsia1995; 36:649–657. DOI:10.1111/j.1528-1157.1995.tb01041.x
[29] Banerjee S, Paul P,  Talib VJ. Serum prolactin in seizure disorders. Indian Pediatr. 2004;41(8):827-31. 
[30] Shukla G, Bhatia M, Vivekanandhan S, Gupta N, Tripathi M, Srivastava A, Pandey RM,& Jain S. Serum prolactin levels for differentiation of nonepileptic versus true seizures: limited utility. Epilepsy Behav.2004;  5(4):517-21. doi: 10.1016/j.yebeh.2004.03.004. 
[31] Stöcklin B, Fouzas S, Schillinger P, Cayir S, Skendaj R, Ramser M et al. Copeptin as a Serum Biomarker of Febrile Seizures. PLoS ONE. 2015;10(4):e0124663. doi:10.1371/journal.pone.0124663
[32] Macooie AA, Pashapoor N, Yekta Z, and Karamyar M. Serum Prolactin Level after Febrile Seizure versus Epileptic Seizure in 6-Month-Old to 5-Year-Old Children. Iran J Med Sci. 2009; 34(3):177-180.
[33] Fisher RS. Serum prolactin in seizure diagnosis. Neurol Clin Pract. 2016; 6 (2) 100-101; doi: 10.1212/CPJ.0000000000000228